Drug Channels

JUNE 18, 2024

This week, I’m rerunning some popular posts while I prepare for Friday’s live video webinar: The 340B Drug Pricing Program: Trends, Controversies, and Outlook. billion figure was roughly accurate for the AllianceRx Walgreens Pharmacy business. Click here to see the original post from April 2024. All rights reserved.

Specialty Pharmacies 52

Specialty Pharmacies Drug Pricing Hospitals 52

Drug Channels

FEBRUARY 21, 2023

On March 14, 2023, Drug Channels Institute will release The 2023 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers. drug pricing, reimbursement, and dispensing system. drug pricing, reimbursement, and dispensing system. The 2023 Economic Report on U.S.

Specialty Pharmacies 97

Specialty Pharmacies Drug Pricing Biosimilars 97

Drug Channels

MARCH 8, 2023

Next week, Drug Channels Institute will release our 2023 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers. drug pricing, reimbursement, and dispensing system. We’re offering special discounted pricing if you order before April 3, 2023. d/b/a Drug Channels Institute.

Specialty Pharmacies 98

Specialty Pharmacies Drug Pricing 98

Pharma Marketing Network

DECEMBER 8, 2022

Upcoming Informa Connect Events: Speaker Programs Summit – February 27-March 1, 2023. Pharma Forum – March 19-22, 2023. PAP – Patient Assistance & Access Programs – March 20-22, 2023. Hub and Specialty Pharmacy Models East – March 20-22, 2023.

Specialty Pharmacies 40

Specialty Pharmacies Drug Pricing 40

Proxsys Rx

OCTOBER 25, 2024

For more information on any aspect of developing & managing a successful 340B program AND/OR retail and specialty pharmacies, contact: HOWARD HALL C: 214.808.2700 | howard.hall@proxsysrx.com FULL POST According to a graphic published on its website, in 2023 Johnson & Johnson provided $42.8

Specialty Pharmacies 52

Specialty Pharmacies Hospitals Drug Pricing 52

Proxsys Rx

MAY 1, 2023

It’s a sad truth that accurately reflects the current state of 340B manufacturer restrictions, particularly in the wake of the January 30, 2023 decision by the U.S. If they’re not loaded, I have to provide, to the wholesalers, pricing for all of the NDCs (National Drug Codes) which have been newly impacted.

Drug Pricing 52

Drug Pricing Hospitals Specialty Pharmacies 52

Proxsys Rx

APRIL 10, 2023

It’s a sad truth that accurately reflects the current state of 340B manufacturer restrictions, particularly in the wake of the January 30, 2023 decision by the U.S. If they’re not loaded, I have to provide, to the wholesalers, pricing for all of the NDCs (National Drug Codes) which have been newly impacted.

Drug Pricing 52

Drug Pricing Hospitals Specialty Pharmacies 52

Putting Patients First Blog

NOVEMBER 14, 2023

NHC Comments on Request for Information: Medicare Transaction Facilitator (MTF) for the Medicare Drug Price Negotiation Program (PDF) November 13, 2023 Benjamin Stidham, Contract Specialist Centers for Medicare & Medicaid Services U.S. Pharmacy benefit managers: transparency, accountability, and impact on patient care.

Drug Pricing 40

Drug Pricing Specialty Pharmacies HIPAA Payment Processing 40

Proxsys Rx

APRIL 19, 2024

Between late 2019 and the end of 2023, ProxsysRx’s 340B Support program went from Zero to more than $500 million in savings generated for the hospitals and health systems we serve. Understand, and master, your 340B specialty pharmacy opportunities. The 340B revenue potential of specialty pharmacy is staggering.

Specialty Pharmacies 52

Specialty Pharmacies Hospitals Drug Pricing Documentation 52

Putting Patients First Blog

JULY 2, 2024

General Comments The NHC appreciates CMS’ commitment to actively engaging with stakeholders, including patients, consumer advocates, and health experts, in implementing the Medicare Drug Price Negotiation Program (DPNP). This includes collecting data on utilization management practices, formulary changes, and patient experiences.

Drug Pricing 52

Drug Pricing Insurance Coverage and Processing Labelling HIPAA 52

Proxsys Rx

JANUARY 12, 2024

Between late 2019 and the end of 2023, ProxsysRx’s 340B Support program went from Zero to $435 million in savings generated for the hospitals and health systems we serve. Understand, and master, your 340B specialty pharmacy opportunities. The 340B revenue potential of specialty pharmacy is staggering.

Specialty Pharmacies 52

Specialty Pharmacies Hospitals Drug Pricing Packaging 52

Putting Patients First Blog

JANUARY 27, 2025

Baez et al., “Social Determinants of Health, Health Disparities, and Adiposity,” Progress in Cardiovascular Diseases 78 (2023): 1726, published in final edited form May 11, 2023, [link] 3 National Health Council. October 2023. November 2023. November 2023. Research Series Issue 4.

Insurance Coverage and Processing 40

Insurance Coverage and Processing Biosimilars Communication Department of Veterans Affairs 40

Drug Channels

MARCH 11, 2025

drug pricing, reimbursement, and dispensing system. For 2024, DCI estimates that total prescription dispensing revenues at retail, mail, long-term care, and specialty pharmacies reached $683 billion, up 9% from the 2023 figure. Its the 16th edition of our popular and comprehensive examination of the entire U.S.

Specialty Pharmacies 97

Specialty Pharmacies Drug Pricing 97

Proxsys Rx

JUNE 4, 2025

The evolving legal and legislative landscape surrounding the 340B Drug Pricing Program has significant implications for hospitals’ specialty pharmacies. Here’s a breakdown of the new developments and their likely impacts: Recent 340B changes and their impact on specialty pharmacies 1.

Specialty Pharmacies 52

Specialty Pharmacies Hospitals Documentation Inventory Control 52